Abbott, Oasmia Join To Market New Cancer Medicine For Dogs – Update – RTT News
Abbott, Oasmia Join To Market New Cancer Medicine For Dogs - Update RTT News The medicine is a new formulation of the active ingredient paclitaxel, which is used in the treatment of cancer in humans since 1993. by RTT Staff Writer. |
If you enjoyed this post, please consider to leave a comment or subscribe to the feed and get future articles delivered to your feed reader.

Comments
No comments yet.
Sorry, the comment form is closed at this time.